OMIA group 2080
Epidermolysis bullosa, simplex, PLEC-related
The chain reaches the human disease epidermolysis bullosa simplex 5A, Ogna type, which Mondo defines as: “A basal subtype of epidermolysis bullosa simplex (EBS) characterized by sometimes widespread, primarily acral blistering.” It reaches 3 more human diseases, listed below.
The chain
From the animal disease to the drugs. The page shows what each step found and where the chain stopped. It does not say whether the animal is a model of a human disease.
-
Animal disease
Reached
OMIA records it in 1 species entry marked as a defect.
-
Human disease
Reached
4 Mondo diseases.
-
Human gene
Reached
1 human gene.
-
Target evidence
Reached
4 Open Targets associations, with a best score of 0.79.
-
Drugs
Stopped here
No ChEMBL drug acts on a human gene of the group's target evidence.
The chain stopped at Drugs: No ChEMBL drug acts on a human gene of the group's target evidence.
Natural-model score
How complete and how well supported the chain to each human disease is, out of 100, by stated rules. It does not say that the animal is a validated model of the human disease. How the score works.
56.7 out of 100
| Part | Computed from | Points |
|---|---|---|
| Target evidence | Open Targets score of 0.79 | 27.7 of 35 |
| Drugs | No drug has been tested for this disease, and none acts on its genes | 0.0 of 25 |
| Ortholog | One to one ortholog | 20.0 of 20 |
| Both routes | One route found this disease | 5.0 of 10 |
| Species | 1 naturally occurring species entry marked as a defect | 4.0 of 10 |
56.0 out of 100
| Part | Computed from | Points |
|---|---|---|
| Target evidence | Open Targets score of 0.77 | 27.0 of 35 |
| Drugs | No drug has been tested for this disease, and none acts on its genes | 0.0 of 25 |
| Ortholog | One to one ortholog | 20.0 of 20 |
| Both routes | One route found this disease | 5.0 of 10 |
| Species | 1 naturally occurring species entry marked as a defect | 4.0 of 10 |
55.3 out of 100
| Part | Computed from | Points |
|---|---|---|
| Target evidence | Open Targets score of 0.75 | 26.3 of 35 |
| Drugs | No drug has been tested for this disease, and none acts on its genes | 0.0 of 25 |
| Ortholog | One to one ortholog | 20.0 of 20 |
| Both routes | One route found this disease | 5.0 of 10 |
| Species | 1 naturally occurring species entry marked as a defect | 4.0 of 10 |
53.2 out of 100
| Part | Computed from | Points |
|---|---|---|
| Target evidence | Open Targets score of 0.69 | 24.2 of 35 |
| Drugs | No drug has been tested for this disease, and none acts on its genes | 0.0 of 25 |
| Ortholog | One to one ortholog | 20.0 of 20 |
| Both routes | One route found this disease | 5.0 of 10 |
| Species | 1 naturally occurring species entry marked as a defect | 4.0 of 10 |
Species
The chain follows only the species entries that OMIA marks as a defect.
| Species | Scientific name | OMIA entry | A defect |
|---|---|---|---|
| dog | Canis lupus familiaris | OMIA:002080-9615 | Yes |
Genes
Each gene OMIA records for a species entry, and the human gene it reaches through Ensembl's orthologs.
| Species | Animal gene | Human gene | Ortholog |
|---|---|---|---|
| dog | PLEC plectin NCBI Gene 482083 | PLEC Ensembl | one to one |
Human diseases
Two routes lead from an OMIA group to a Mondo human disease: OMIA's own Mondo link, and the group's OMIM numbers through Mondo's cross-references.
- OMIA's own Mondo link: OMIA links the group to no Mondo disease.
- OMIA's OMIM numbers: found a disease.
| Mondo disease | Name | Found by |
|---|---|---|
| MONDO:0007555 | epidermolysis bullosa simplex 5A, Ogna type A basal subtype of epidermolysis bullosa simplex (EBS) characterized by sometimes widespread, primarily acral blistering. | OMIA's OMIM numbers |
| MONDO:0009181 | epidermolysis bullosa simplex 5B, with muscular dystrophy A basal subtype of epidermolysis bullosa simplex (EBS) characterized by generalized blistering associated with muscular dystrophy. | OMIA's OMIM numbers |
| MONDO:0012807 | epidermolysis bullosa simplex 5C, with pyloric atresia A basal subtype of epidermolysis bullosa simplex (EBS) characterized by generalized severe blistering with widespread congenital absence of skin and pyloric atresia. | OMIA's OMIM numbers |
| MONDO:0014661 | epidermolysis bullosa simplex with nail dystrophy A basal subtype of epidermolysis bullosa simplex (EBS) characterized by generalized skin blistering associated with severe nail dystrophy. | OMIA's OMIM numbers |
Target evidence
Each Open Targets association between one of the group's human genes and one of its human diseases, with its overall score and the score for each kind of evidence.
| Human gene | Human disease | Score | Evidence | Kinds of evidence |
|---|---|---|---|---|
| PLEC | epidermolysis bullosa simplex 5B, with muscular dystrophy | 0.79 | 5,865 | Genetic association 0.86 Genetic literature 0.83 Animal model 0.49 Literature 0.05 |
| PLEC | epidermolysis bullosa simplex 5A, Ogna type | 0.77 | 5,844 | Genetic association 0.84 Genetic literature 0.78 Animal model 0.74 |
| PLEC | epidermolysis bullosa simplex 5C, with pyloric atresia | 0.75 | 5,850 | Genetic association 0.85 Genetic literature 0.81 Animal model 0.41 |
| PLEC | epidermolysis bullosa simplex with nail dystrophy | 0.69 | 5,852 | Genetic association 0.91 Genetic literature 0.61 Animal model 0.56 Literature 0.02 |
Drugs
No ChEMBL drug acts on a human gene of the group's target evidence.